Advanced Biomedical Technologies, Inc.

ABMT · OTC
Analyze with AI
10/31/2022
10/31/2021
10/31/2020
10/31/2019
Operating Activities
Net Income-$515-$729-$672-$949
Dep. & Amort.$19$41$60$21
Deferred Tax$0$0$0$0
Stock-Based Comp.$0$0$0$0
Change in WC-$267-$201$1,186$157
Other Non-Cash$29$44$72$28
Operating Cash Flow-$735-$846$647-$743
Investing Activities
PP&E Inv.$0-$52-$31-$19
Net Acquisitions$0$0$0$0
Inv. Purchases$0$0$0$0
Inv. Sales/Matur.$0$0$0$0
Other Inv. Act.$0$0$0$0
Investing Cash Flow$0-$52-$31-$19
Financing Activities
Debt Repay.$711$756-$44$0
Stock Issued$0$0$0$0
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.-$7-$30-$384$760
Financing Cash Flow$704$726-$428$760
Forex Effect-$2$7$8-$0
Net Chg. in Cash-$32-$165$196-$1
Supplemental Information
Beg. Cash$37$202$6$7
End Cash$5$37$202$6
Free Cash Flow-$735-$897$616-$761
Advanced Biomedical Technologies, Inc. (ABMT) Financial Statements & Key Stats | AlphaPilot